联邦听证会开始批准一项74亿美元的Purdue Pharma解决阿片危机方案。 Federal hearings begin to approve a $7.4 billion Purdue Pharma settlement over opioid crisis.

联邦破产听证会已开始为Purdue Pharma最后敲定一项74亿美元的解决计划,目的是解决与该公司在类阿片危机中的作用有关的索偿要求。 Federal bankruptcy hearings have begun to finalize a $7.4 billion settlement plan for Purdue Pharma, aiming to resolve claims tied to the company’s role in the opioid crisis. 程序将决定是否批准该协议,其中包括萨克勒家族的缴款和该公司的资产,以便向前迈进。 The proceedings will determine whether the agreement, which includes contributions from the Sackler family and the company’s assets, will be approved to move forward. 结果可能影响未来对受害者的问责和赔偿。 The outcome could impact future accountability and compensation for victims.